Correlation analysis of VEGF and PTEN expression in gingival carcinoma

Abstract

Abstract: PURPOSE: To study the expression of vascular endothelial growth factor (VEGF) and phosphatase and tensin homolog (PTEN) in gingival carcinoma and their correlation in order to provide reference for clinical treatment. METHODS: Sixty-six gingival cancer patients were determined by pathological examination, among which 31 were well-differentiated, 20 were moderately differentiated and 15 were poorly differentiated.15 adjacent normal tissues were chosen as control group. The expression of VEGF and PTEN was examined by immunohistochemical method. Correlation analysis was performed with SPSS13.0 software package. RESULTS: The positive rate of PTEN in control group was significantly higher than other groups (P<0.05). The expression of VEGF in poorly differentiated group was significantly higher than other groups (P<0.05). Correlation analysis showed that the expression of VEGF was positively correlated to recurrence and lymph node metastasis (P<0.05); PTEN was negatively correlated to recurrence and lymph node metastasis (P<0.05); VEGF and PTEN in gingival carcinoma was negatively correlated (P<0.05). CONCLUSIONS: The increased expression of VEGF and decreased expression of PTEN in gingival carcinoma may play a mutual role in the development of gingival cancer.

Key words: Gingival cancer, VEGF, Immunohistochemistry, PTEN

LI Jing-dong, LIANG Rui-ying, ZHAO Yan-ping, XU Yan-li. Correlation analysis of VEGF and PTEN expression in gingival carcinoma[J]. Shanghai Journal of Stomatology, 2014, 23(5): 619-623.

References

[1] 郭朱明,王顺兰,张诠, 等. 116例牙龈癌的治疗与预后分析 [J]. 癌症, 2008, 27(3): 307-310.
[2] 张瑛, 钱忠义, 普苹, 等. VEGF、MMP-9、TIMP-2在口腔颌面部鳞癌中的表达研究 [J]. 口腔医学研究, 2012, 28(11): 1141-1144.
[3] 蔡小攀. 口腔鳞癌生物学特点与HIF-1ɑ和VEGF等基因表达的关系 [D].上海: 第二军医大学, 2010.
[4] 杨雨晗, 邓缅. PTEN基因调控口腔鳞癌细胞TCA-8113增殖及凋亡 [J]. 第三军医大学学报, 2011, 33(14): 1484-1487.
[5] Liu Z, Li L, Yang Z, et al. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma [J]. BMC Cancer, 2010, 10: 270.
[6] Jimenez WA, Sardi A, Ledakis P, et al. The role of VEGFR-2 expression in outcomes and survival of patients with peritoneal carcinomatosis from appendiceal cancer[J]. Eur J Surg Oncol, 2013, 39(12): 1415-1422.
[7] Alyasiri NS, Ali A, Kazim Z, et al. Aberrant promoter methylation of PTEN gene among Indian patients with oral squamous cell carcinoma [J]. Int J Biol Markers, 2013, 28(3): 298-302.
[8] Gan YH, Zhang S. PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells [J]. Oral Oncol, 2009, 45(10): e150-154.
[9] Goel HL, Chang C, Pursell B, et al. VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer[J]. Cancer Discov, 2012, 2(10): 906-921.
[10] Seton-Rogers S. Tumour suppressors: Nuclear PTEN [J]. Nat Rev Cancer, 2013, 13(9): 606.
[11] Akiyama-Abe A, Minaguchi T, Nakamura Y, et al. Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas[J]. Br J Cancer, 2013, 109(6): 1703-1710.
[12] Price TJ, Hardingham JE, Lee CK, et al. Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab [J]. Cancer Med, 2013, 2(3): 277-285.